GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
1.150
-0.020 (-1.71%)
At close: Apr 23, 2026, 4:00 PM EDT
1.130
-0.020 (-1.74%)
After-hours: Apr 23, 2026, 6:04 PM EDT
GeoVax Labs Market Cap
GeoVax Labs has a market cap or net worth of $3.33 million as of April 23, 2026. Its market cap has decreased by -74.75% in one year.
Market Cap
3.33M
Enterprise Value
1.08M
1-Year Change
-74.75%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since September 11, 2019, GeoVax Labs's market cap has increased from $239.88K to $3.33M, an increase of 1,286.72%. That is a compound annual growth rate of 48.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 3.38M | -53.92% |
| Dec 31, 2025 | 7.34M | -68.49% |
| Dec 31, 2024 | 23.31M | 141.85% |
| Dec 29, 2023 | 9.64M | -41.93% |
| Dec 30, 2022 | 16.60M | -28.16% |
| Dec 31, 2021 | 23.10M | 92.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alzamend Neuro | 4.07M |
| AIM ImmunoTech | 3.98M |
| Artelo Biosciences | 3.80M |
| GRI Bio | 3.64M |
| Matinas BioPharma Holdings | 3.52M |
| Azitra | 3.46M |
| SciSparc | 3.39M |
| Silexion Therapeutics | 3.33M |